New South Wales (NSW) has a strong track record in developing livestock vaccines, treatments and diagnostics for animals. Companies within this sector have developed a range of innovative products, including Peptech Animal Health’s development of the world’s first peptide-based animal contraceptive.

These commercial developments are enhanced by an extensive network of research laboratories operated by the NSW Department of Primary Industries. Another key biotechnology asset is the disease free trading partner status of the State.